In a strategic push to transform India’s pharmaceutical and biotech landscape, the government recently outlined and invited ...

Swiss pharma giant Roche today announced that the first Phase III (FENhance 2) of two pivotal, similarly-designed Phase III ...

US obesity drug developer Metsera presented detailed results from two Phase IIb trials for its weight-loss drug candidate, ...

US oncology company Summit Therapeutics and its partner Akeso have communicated results from the Phase III HARMONi-A trial - ...

US biopharma BridgeBio Pharma has presented data from the ATTRibute-CM study, showing that acoramidis significantly reduces ...

US clinical-stage genetic medicines company MeiraGTx Holdings saw its shares rise 15% to $9.74 pre-market today, as it ...

Spanish dermatology specialist Almirall has announced its financial results for the first nine months of 2025, presenting a ...

A biotech company developing programmable mRNA therapeutics designed to control the location, timing, intensity and duration ...

A frenzy of M&A deals hit the pharma sector in October, with Novo Nordisk, Bristol Myers Squibb, Eli Lilly and Novartis the big players that announced acquisitions.

French biotech EVerZom has signed its first research partnership with compatriot GENFIT to evaluate EViv, an exosome-based ...

A broad majority in the Danish Parliament has reached an agreement on multi-year billion-dollar investments in Danish ...

The Association of the British Pharmaceutical Industry has urged the UK government to use the upcoming Budget to address what ...